FI953506A - Monia lääkeaineita vastaan vastustuskykyisten kasvainten lääkkeinä käyttökelpoiset diaryylialkyylipiperidiinit - Google Patents

Monia lääkeaineita vastaan vastustuskykyisten kasvainten lääkkeinä käyttökelpoiset diaryylialkyylipiperidiinit Download PDF

Info

Publication number
FI953506A
FI953506A FI953506A FI953506A FI953506A FI 953506 A FI953506 A FI 953506A FI 953506 A FI953506 A FI 953506A FI 953506 A FI953506 A FI 953506A FI 953506 A FI953506 A FI 953506A
Authority
FI
Finland
Prior art keywords
pct
tumors
diarylalkylpiperidines
medicines
resistant
Prior art date
Application number
FI953506A
Other languages
English (en)
Swedish (sv)
Other versions
FI953506A0 (fi
FI112474B (fi
Inventor
Sai Prasad Sunkara
Jules Freedman
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of FI953506A0 publication Critical patent/FI953506A0/fi
Publication of FI953506A publication Critical patent/FI953506A/fi
Application granted granted Critical
Publication of FI112474B publication Critical patent/FI112474B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI953506A 1993-01-21 1995-07-20 Menetelmä kasvainlääkkeinä käyttökelpoisten diaryylialkyylipiperidiiniyhdisteiden valmistamiseksi FI112474B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US656993A 1993-01-21 1993-01-21
PCT/US1993/012300 WO1994017040A1 (en) 1993-01-21 1993-12-17 Diarylalkyl piperidines useful as multi-drug resistant tumor agents
US9312300 1993-12-17
US656993 1996-05-28

Publications (3)

Publication Number Publication Date
FI953506A0 FI953506A0 (fi) 1995-07-20
FI953506A true FI953506A (fi) 1995-07-20
FI112474B FI112474B (fi) 2003-12-15

Family

ID=21721516

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953506A FI112474B (fi) 1993-01-21 1995-07-20 Menetelmä kasvainlääkkeinä käyttökelpoisten diaryylialkyylipiperidiiniyhdisteiden valmistamiseksi

Country Status (20)

Country Link
US (1) US5648365A (fi)
EP (1) EP0680470B1 (fi)
JP (1) JP3398748B2 (fi)
KR (1) KR100377280B1 (fi)
AT (1) ATE150748T1 (fi)
AU (1) AU679723B2 (fi)
CA (1) CA2152794C (fi)
DE (1) DE69309310T2 (fi)
DK (1) DK0680470T3 (fi)
ES (1) ES2102830T3 (fi)
FI (1) FI112474B (fi)
GR (1) GR3023188T3 (fi)
HU (1) HUT72078A (fi)
IL (1) IL108369A (fi)
MX (1) MX9400563A (fi)
NO (1) NO305166B1 (fi)
NZ (1) NZ261414A (fi)
TW (1) TW243445B (fi)
WO (1) WO1994017040A1 (fi)
ZA (1) ZA94317B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU662602B2 (en) * 1992-02-06 1995-09-07 Merrell Dow Pharmaceuticals Inc. Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives
AU6366000A (en) * 1999-07-23 2001-02-13 Colorado State University Research Foundation Multidrug resistance pump inhibitors and uses thereof
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US20030109448A1 (en) * 2001-11-07 2003-06-12 Crowley Kathleen S. Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
KR100656490B1 (ko) 2001-11-26 2006-12-12 삼성에스디아이 주식회사 풀칼라 유기전계 발광표시소자 및 그의 제조방법
US8153184B2 (en) * 2001-11-26 2012-04-10 Samsung Mobile Display Co., Ltd. Organic EL display device and method of manufacturing the same
PT3732994T (pt) 2013-02-08 2022-12-02 Gen Mills Inc Produtos alimentares com reduzido teor de sódio
CN110372571B (zh) * 2018-04-12 2022-11-15 中国科学院大连化学物理研究所 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1049377B (de) * 1952-04-03 1959-01-29 Abbott Laboratories, North Chicago, 111. (V. St. A.) Verfahren zur Herstellung von substituierten Vinylpiperidinen
US2898339A (en) * 1957-07-29 1959-08-04 Wm S Merrell Co N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
US4035372A (en) * 1976-08-13 1977-07-12 G. D. Searle & Co. 4-{[4-(Diphenylmethyl)-1-piperidinyl]methyl}benzenamines
EP0228893A3 (en) * 1985-12-20 1990-01-03 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl group in allergy treatment
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
US4990511A (en) * 1988-08-03 1991-02-05 Takeda Chemical Industries, Ltd. Amide compounds, their production and use
DE69003200T2 (de) * 1989-06-19 1994-01-20 Wellcome Found Arylsubstituierte Aminderivate verwendbar in der Krebstherapie.
GB9000305D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Anticholinergic agents
EP0467435A3 (en) * 1990-07-19 1992-04-01 Akzo N.V. Benzhydryl derivatives having calmodulin inhibitor properties
ES2112268T3 (es) * 1990-08-14 1998-04-01 Hoechst Marion Roussel Inc Nuevos 19-nor-esteroides que tienen en posicion 11beta una cadena carbonada que comprende una funcion amida, su preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
AU662602B2 (en) * 1992-02-06 1995-09-07 Merrell Dow Pharmaceuticals Inc. Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives

Also Published As

Publication number Publication date
AU6014894A (en) 1994-08-15
CA2152794A1 (en) 1994-08-04
HU9502195D0 (en) 1995-09-28
JP3398748B2 (ja) 2003-04-21
IL108369A0 (en) 1994-04-12
US5648365A (en) 1997-07-15
GR3023188T3 (en) 1997-07-30
NO305166B1 (no) 1999-04-12
DE69309310D1 (de) 1997-04-30
NO952885L (no) 1995-09-20
ZA94317B (en) 1994-08-18
EP0680470B1 (en) 1997-03-26
FI953506A0 (fi) 1995-07-20
NZ261414A (en) 1997-06-24
FI112474B (fi) 2003-12-15
IL108369A (en) 1999-08-17
HUT72078A (en) 1996-03-28
KR100377280B1 (ko) 2003-07-18
DK0680470T3 (fi) 1997-04-28
ATE150748T1 (de) 1997-04-15
DE69309310T2 (de) 1997-11-06
MX9400563A (es) 1994-07-29
AU679723B2 (en) 1997-07-10
CA2152794C (en) 1999-04-06
KR960700230A (ko) 1996-01-19
TW243445B (fi) 1995-03-21
EP0680470A1 (en) 1995-11-08
JPH08505870A (ja) 1996-06-25
NO952885D0 (no) 1995-07-20
ES2102830T3 (es) 1997-08-01
WO1994017040A1 (en) 1994-08-04

Similar Documents

Publication Publication Date Title
ITMI921601A1 (it) Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
ATE193883T1 (de) Verbindungen und ihre zusammensetzungen mit entzündungshemmenden und anti-thrombotischen wirkungen
AR016001A1 (es) Uso de polimeros de amina alifatica para la fabricacion de medicamentos para la reduccion de niveles de oxalato en un paciente
DE69425431T2 (de) 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
FI953506A (fi) Monia lääkeaineita vastaan vastustuskykyisten kasvainten lääkkeinä käyttökelpoiset diaryylialkyylipiperidiinit
NO952683L (no) Nye colon- eller ileum-spesifikke steroidderivater
DE69216221D1 (de) Verbindungen mit guanidin-struktur und diese enthaltende pharmazeutische zusammensetzungen
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
KR950700061A (ko) 테트라아릴에틸렌에 의한 다중 약물 내성의 역전(reversal of multi -drug resistance by tetraarylethylenes)
KR960703593A (ko) (R)-암로디핀에 의한 평활근 세포 이동의 억제 (Inhibition of Smooth Muscle Cell Migration by (R)-Amlodipine)
KR910011807A (ko) 4-벤질-5-페닐-2,4-디히드로-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그 의 용도
ES2094638T3 (es) N-acilpirrolidinas y medicamentos para el tratamiento o la prevencion de los desordenes relacionados con la colecistoquinina y la gastrina.
FI950209A (fi) Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset
ATE169922T1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
DE69211161T2 (de) Antibiotische 7-aminonaphthazarinderivate
KR960021021A (ko) 인터루킨-1β의 생성 및 종양 괴사 인자 α의 방출을 억제하기 위한 약제
ATE313323T1 (de) Pharmazeutische zubereitungen
ATE150030T1 (de) Ureidoacetamid-derivate,irhe herstellung und sie enthaltende medikamente
KR960700053A (ko) 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)
TH51075A3 (th) ตัวยับยั้งเอนไซม์ย่อยสลายโปรตีน
TH19877A (th) อนุพันธ์แอนธราไซคลิโนน